• ‘Compelling’ mid-stage data for Vertex’ CF drugs pharmatimes
    July 21, 2017
    Vertex Pharmaceuticals has unveiled “compelling data” from early and mid-stage studies assessing three experimental triple combination regimens for patients with certain forms of cystic fibrosis (CF
PharmaSources Customer Service